Biocon
-
Biocon employee found dead in Electronic City campus in Bengaluru, investigation launched
Karnataka | Dec 31, 2025, 10:19 AM ISTPolice have registered a case and initiated an investigation. Police officials confirmed that no note was recovered from the spot. The exact cause behind the employee's death is not yet clear.
-
Biocon Biologics facility gets EU GMP certification for Bevacizumab
Business | Apr 28, 2023, 06:46 PM ISTBiocon Biologics' facility has received a certificate of GMP compliance for Bevacizumab from the representative European inspection authority -- Health Products Regulatory Authority (HPRA), Ireland.
-
Biocon Biologics to offer 15% stake to Serum Institute Life Sciences at valuation of USD 4.9 bn
Business | Sep 16, 2021, 11:02 PM ISTBiocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion. Serum Institute Life Sciences (SILS) is a subsidiary of Serum Institute of India (SII).
-
Jeetega India | 'Ramping up vaccine production is complex': Kiran Mazumdar Shaw, Chairperson Biocon
News | May 09, 2021, 02:40 PM ISTExecutive Chairperson, Biocon Kiran Mazumdar Shaw spoke at the India TV Conclave. She talked about the hurdles in ramping up vaccination. Apart from this, she said, "People who haven't ever tested positive for COVID 19 should be prioritized for vaccination, as they're more susceptible to it".
-
Biocon Q3 net profit falls 19 per cent to Rs 186.6 cr
Business | Jan 22, 2021, 11:38 AM ISTExecutive Chairperson Kiran Mazumdar-Shaw said the consolidated revenue for Q3 FY21 was driven by 13 per cent growth in research services and 11 per cent in biosimilar business segments.
-
DGCI approved Biocon drug to be used for treatment of moderate to severe COVID-19 patients
Health | Jul 13, 2020, 06:26 PM ISTThe executive chairperson of Biocon, Kiran Mazumdar Shaw said, "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release distress syndrome (ADRS) patients caused by the COVID-19".
-
Biocon's Itolizumab approved as life-saving COVID-19 medicine; Kiran Mazumdar-Shaw announces details
India | Jul 13, 2020, 03:17 PM ISTKiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited, announced Monday that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19.
-
Biocon drug receives DCGI nod for use in moderate to severe COVID-19 patients
Business | Jul 11, 2020, 05:22 PM ISTBiotechnology major Biocon on Saturday announced that its "breakthrough drug," Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to severe COVID-19 patients.
-
USFDA accepts proposed biosimilar application by Mylan, Biocon for review
Business | Mar 09, 2020, 12:51 PM ISTThe US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.
-
Indian Biotechnology major Biocon to make 3 generic drugs in China
Business | Sep 14, 2019, 10:49 PM ISTBiotechnology major Biocon would make three generic drugs for hard-selling in China through partnership, the company said on Saturday.
-
I don't give much thought to rich list: Biocon's Kiran Mazumdar-Shaw
Business | Oct 06, 2017, 04:13 PM ISTBiotechnology pioneer Kiran Mazumdar-Shaw says the latest list of 100 rich persons in India reflects the state of the economy.
-
Shah Rukh Khan finds his role model in this Indian woman and no, she's not from Bollywood!
Bollywood | Apr 01, 2017, 06:23 PM ISTShah Rukh reveals where he draws his inspiration for success from. The Bollywood superstar considers Kiran Mazumdar Shaw, the chairperson of leading Indian biotech company, Biocon, his role model.
-
Biocon Q3 net dips 13% to Rs 91 crore; to offload 10-15% in Syngene
Jan 23, 2015, 05:11 PM ISTNew Delhi: Biotech firm Biocon reported a 13 percent dip in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 percent stake in its research services arm Syngene.The company
-
'Biocon planning to set up manufacturing unit in Vizag'
Dec 15, 2014, 11:10 AM ISTHyderabad: Pharmaceutical giant Biocon is contemplating setting up a manufacturing facility in Visakhapatnam, Andhra Pradesh government said Sunday."Biocon Chairperson and Managing Director (CMD) Kiran Mazumdar Shaw met Chief Minister N Chandrababu Naidu at his residence
-
Biocon Q2 net flat at Rs 102 crore
Oct 22, 2014, 05:14 PM ISTNew Delhi: Biotechnology major Biocon today reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014.The company had posted a net profit after tax and
-
Global Economy Prize for India's biotech queen
Jun 24, 2014, 07:35 AM ISTBangalore: India's biotechnology queen and Biocon chairperson Kiran Mazumdar-Shaw has been awarded the coveted Global Economy Prize for business by the Kiel Institute in Germany during its centenary celebrations."Mazumdar-Shaw is the first Indian woman and
-
Biocon Q4 net dips 54% at Rs 113 crore
Apr 26, 2014, 05:17 PM ISTNew Delhi: Biotechnology major Biocon today reported a 54.51% decline in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014. The company had posted a net profit of
-
Biocon Q1 net rises 19% to Rs 93.5 cr
Jul 26, 2013, 11:58 AM ISTNew Delhi, July 26: Biocon has reported a 18.65 per cent rise in consolidated net profit at Rs 93.50 for the first quarter ended June 30, 2013 mainly on account of strong performance in the
-
Biocon group net up 51% in fiscal 2013
Apr 28, 2013, 03:09 PM ISTBangalore, April 28: India's biotechnology major Biocon Ltd posted consolidated net profit of Rs.509 crore for fiscal 2012-13, registering a whopping 51 percent year-on-year (YoY) growth over previous fiscal (2011-12) at Rs.338 crore.In a regulatory
-
Biocon Q3 net up 9% at Rs. 93 cr
Jan 25, 2013, 01:01 PM ISTNew Delhi, Jan 25: Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.The company had posted a net